<DOC>
	<DOCNO>NCT02468778</DOCNO>
	<brief_summary>The HeartMate PHP System temporary ( &lt; 6 hour ) ventricular assist device indicate use high risk percutaneous coronary intervention ( PCI ) perform elective urgent , hemodynamically stable patient severe coronary artery disease depress leave ventricular ejection fraction .</brief_summary>
	<brief_title>Supporting Patients Undergoing HIgh-Risk PCI Using High-Flow PErcutaneous Left Ventricular Support Device ( SHIELD II )</brief_title>
	<detailed_description>Prospective , randomize , multi-center , open-label trial HeartMate PHP 100 site US . Control device Abiomed Impella device approve use high-risk PCI . Nonrandomized roll-in phase : Each site must first enroll treat 6 patient ( 3 PHP 3 Impella per site ) Randomized phase : Up 425 patient undergoing PCI per Inclusion/Exclusion criterion .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>At least 18 year age Patient undergoing elective urgent high risk PCI procedure hemodynamically stable Patient indicate revascularization least one de novo restenotic lesion native coronary vessel bypass graft A heart team , include cardiac surgeon , determine high risk PCI acceptable therapeutic option The presence complex coronary artery disease ( CAD ) make hemodynamic instability result repeat episode reversible myocardial ischemia PCI likely . Complex CAD define : ejection fraction ≤35 % AND least one following : intervention last patent coronary conduit , OR intervention unprotected leave main artery , OR intervention patient present triple vessel disease define least one significant stenosis ( least 50 % diameter stenosis visual assessment ) three major epicardial territory Written , sign , date informed consent • Emergency PCI Any prior coronary revascularization within last six month Myocardial infarction baseline define : ST Elevation MI ( STEMI ) : Subject clinical symptom and/or ECG change ( new pathological Q wave 2 contiguous lead ) consistent acute ST elevation MI ( STEMI ) within 72 hour prior index procedure . NonSTEMI : Hemodynamically unstable biomarker elevation ( CKMB Troponin &gt; 1x URL ) and/or evidence least 1 consecutive troponin CKMB value trend downward previous value . URL = upper range limit , define 99th percentile normal reference range Cardiac arrest within 24 hour procedure require CPR defibrillation Hemodynamic support HeartMate PHP postPCI anticipate Cardiogenic shock ( systolic blood pressure ( SBP ) &lt; 90 mmHg &gt; 1 hour either cool clammy skin OR oliguria OR alter sensorium AND cardiac index &lt; 2.2 L/min/m2 ) Mural thrombus leave ventricle History aortic valve replacement Documented presence aortic stenosis ( orifice area 1.5cm2 less ) Moderate severe aortic insufficiency echocardiographic assessment Severe peripheral vascular disease Known abnormalities aorta would preclude surgery , include aneurysm significant tortuosity calcification Patient hemodialysis Liver dysfunction elevation liver enzymes bilirubin level ≥ 3x upper limit normal ( ULN ) INR ( International Normalized Ratio ) ≥2 lactate dehydrogenase ( LDH ) &gt; 2.5x ULN . Uncorrectable abnormal coagulation parameter ( platelet count ≤75000/mm3 INR ≥2.0 fibrinogen ≤1.5 g/l ) Active systemic infection require treatment antibiotic Stroke transient ischemic attack ( TIA ) within 6 month procedure Any allergy intolerance ionic nonionic contrast medium , anticoagulant , antiplatelet therapy drug adequately premedicated Patient pregnant Participation another clinical study investigational drug device meet primary endpoint</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>HeartMate PHP</keyword>
	<keyword>High Risk PCI</keyword>
	<keyword>Left Ventricular Dysfunction</keyword>
	<keyword>Thoratec Corporation</keyword>
</DOC>